Mass General Brigham spun out a new company offering a generative AI platform that can rapidly interpret both structured and unstructured clinical data. Right now, the tool’s primary application is to accelerate and improve the accuracy of patient screening for clinical trials.
The post Mass General Brigham Spins Out Generative AI Startup appeared first on MedCity News.
